Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)

View source ↗

Summary

The clinical trial evaluates Histoacryl (n-butyl-2-cyanoacrylate) embolization of the middle meningeal artery for chronic subdural hematoma and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Histoacryl (n-butyl-2-cyanoacrylate)

Snippet

Sponsor: Aesculap AG | Conditions: Subdural Hematoma, Subdural Hematoma, Chronic | Status: RECRUITING